CytoDyn (CYDY) Enterprise Value (2010 - 2026)
CytoDyn (CYDY) posted Enterprise Value of -$15.7 million for Q1 2026, down 214.23% on a QoQ basis from -$5.0 million in Q4 2025, and up 4.54% year-over-year from -$15.0 million in Q1 2025.
CytoDyn (CYDY) Enterprise Value (2010 - 2026) Analysis & Trends
CytoDyn's Enterprise Value history runs 17 years deep, the most recent figure standing at -$15.7 million for Q1 2026.
- Quarterly Enterprise Value rose 4.54% year-over-year to -$15.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$15.7 million (up 4.54% YoY) and the FY2025 annual result came in at -$11.9 million, down 77.55% from the prior year.
- Enterprise Value was -$15.7 million for Q1 2026 at CytoDyn, down from -$5.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$147000.0 in Q4 2023 and bottomed at -$24.9 million in Q3 2024.
- A 5-year average of -$8.1 million and a median of -$5.1 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 97.75% — and 2024, when it slumped 14413.61%.
- CytoDyn's Enterprise Value stood at -$200000.0 in 2022, then grew by 26.5% to -$147000.0 in 2023, then slumped by 14413.61% to -$21.3 million in 2024, then jumped by 76.65% to -$5.0 million in 2025, then plunged by 214.23% to -$15.7 million in 2026.
- Business Quant data shows CYDY's Enterprise Value at -$15.7 million in Q1 2026, -$5.0 million in Q4 2025, and -$9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | CytoDyn | 258.22 Mn | 258.22 Mn | - | -15.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -15.66 Mn |
| Nov 30, 2025 | -4.98 Mn |
| Aug 31, 2025 | -9.33 Mn |
| May 31, 2025 | -11.90 Mn |
| Feb 28, 2025 | -16.40 Mn |
| Nov 30, 2024 | -21.34 Mn |
| Aug 31, 2024 | -24.92 Mn |
| May 31, 2024 | -6.70 Mn |
| Feb 29, 2024 | -1.40 Mn |
| Nov 30, 2023 | -147,000.00 |
| Aug 31, 2023 | -6.54 Mn |
| May 31, 2023 | -2.54 Mn |
| Feb 28, 2023 | -5.11 Mn |
| Nov 30, 2022 | -200,000.00 |
| Aug 31, 2022 | -4.68 Mn |
| May 31, 2022 | -4.23 Mn |
| Feb 28, 2022 | -1.00 Mn |
| Nov 30, 2021 | -8.88 Mn |
| Aug 31, 2021 | -6.53 Mn |
| May 31, 2021 | -33.94 Mn |